ICM - Rheum 1 Flashcards

(64 cards)

1
Q

uric acid level for hyperuricemia (doesn’t always lead to gout…most asymptomatic)

A

>6.8 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

uric acid is end product of this process

A

purine metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

these dietary excesses increase risk for gout

A

meat, seafood, alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cytokine that is important in pathogenesis of acute gout flare (after crystals released into joint/bursae)

A

IL-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

normal urine uric acid excretion amount in 24 hours

A

250-75 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

these can cause primary overproduction of uric acid

A

deficient HGPRT (salvage pathway), overactive PRPP, G6PD deficiency, F1P aldolase deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

normal amount of filtered load of uric acid that is excreted

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

primary causes of renal underexcretion

A

deficiency in urate exporter, medullary cystic kidney disease (kids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

normal time it takes for acute gouty arthritis to resolve

A

3-10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

80% of initial acute gouty arthritis attacks will be this

A

monoarticular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

crystal in gout joint aspiration

A

monosodium urate monohydrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

crystal in pseudogout joint aspiration

A

calcium pyrophosphate dihydrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

perdiod after 1st gout attack…additional acute attacks (usually within 2 years), shorter asymptomatic periods, sever, prolonged polyarticular flares

A

intercritical gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

solid urate deposits in chronic gout

A

tophi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

to prevent gout progression, want to lower serum urate to below this level (deplete total body urate pool)

A

6 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

typical drug of choice to treat gout

A

NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

alternative to NSAID treatment for gout, but has more side effects (*diarrhea*)

A

colchicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

typical length of corticosteroid treatment for gout

A

5-7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

allopurinol inhibits this enzyme in purine metabolism (to reduce uric acid levels)

A

xanthine oxidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

this is overproduced in CPPD

A

cartilage pyrophosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

where cartilage pyrophosphate crystals deposit

A

joint articular cartilage (hyaline), fibrocartilage, ligaments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

x-ray showing calcification of cartilage and fibrocartilage

A

chondrocalcinosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

where are gout crystals mostly located?

A

synovium (versus CPPD in cartilage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

recessive renal tubular disorder –> older child/adult with hypokalemia, metabolic alklaosis, hypomagnesium, hypocalcuria, leg/arm cramps, weakness, polyuria, nocturia, chondrocalciosis

A

Gitelman syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
acute CPP crystal arthritis --\> lasts 1-3 weeks, flares after parathyroidectomy, mono or oligo-articular arthritis
pseudogout
26
where CPP crystal arthritis most commonly affects
knee (50%), wrist, shoulder, ankle
27
chronic CPP crystal inflammatory arthritis --\> CPPD crystals demonstrable in joint fluid of RA clinical joints, radiographic changes like OA
pseduo-RA
28
possible treatments for BCP crystal deposition arthropathy
NSAIDs, COX-2 inhibitors, steroid injection, irrigation (ultrasound to degrade and lowering serum phosphate also)
29
stain for calcium oxalate crystal test (appear bipyramidal)
alizarin red
30
where are calcium oxalate depositions found? (crystals can break off, causing acute synovitis stimulating synovial cell proliferation and enzyme release--\> articular destruction)
bone, articular cartilage, synovium, periarticular tissue
31
bone that is lost in osteoporosis
trabecular (cortical also in type II)
32
common fractures in type I osteoporosis (postmenopausal women mostly, lost of trabecular bone)
compression fractures and Colles fracture
33
most common fractures in type II osteoporosis
femoral neck, proximal humerus, pelvis
34
risk factors for osteoporosis
female, estrogen depletion, Ca/VitD deficiency, low peak bone mass, decreased physical activity, hypogonadism, hyperthyroidism, smoking, corticosteroids
35
most common clinical finding of osteoporosis
vertebral body compression factors
36
gold standard for diagnosis of osteoporosis (measures bone density and compares to young adult)
DEXA
37
DEXA score in this range is osteopenia
1-2.5 below
38
DEXA score in this range is osteoporosis
less than 2.5
39
who should get DEXA screening?
women\>65, postmenopausal50 with fracture
40
first line pharmacologic treatment for osteoporosis; how do these work?
bisphosphonates; inhibit osteoclast function
41
osteoporosis therapy that helps build bone --\> must limit treatment for 2 years due to increased risk of osteosarcoma
PTH
42
possible treatment for osteoporosis....can decrease pain of vertebral fractures (not used as much anymore)
calcitonin
43
formation of new bone at joint surfaces
eburnation
44
formation of new bone in periarticular tissues
osteophyte formation
45
greatest modifiable risk factor for OA
obesity
46
gene that may be mutated to increase risk of OA
COL2A1
47
radiographic evidence of OA
joint space narrowing, osteophytes, subchondral cysts and sclerosis
48
nodal generalized OA has predisposition to affect these joints
knee, hip and spine
49
first line pharmacological treatment for OA; what is just as effective but has possible GI side effect?
acetaminophen; NSAIDs
50
DDX for OA
Ca pyrophosphate deposition disease, RA, infectious monoarticular disease, psoriatic arthritis
51
chronic inflammatory arthritis that affects the \*synovium\*
RA
52
how do joints feel in RA?
soft and squishy (warm, boggy)
53
cardiac manifestations of RA
pericarditis, myocarditis, CVD
54
pulmonary manifestations of RA
pleural effusion (low glucose and low complement), interstitial fibrosis
55
ocular manifestations of RA
Sjogrens, corneal inflammation, scleritis
56
these are pathognomonic for RA
rheumatoid nodules
57
seropositive RA, neutropenia, splenomegaly, occasional leg ulcers (hematological manifesation of RA)
Felty's syndrome
58
these titer levels are good for prognosis of RA (higher=more severe)
RF
59
very specific test for RA (96%) --\> helpful in diagnosis and prognosis
ACCP
60
anemia seen in RA
normocytic normochromic
61
diagnostic criteria for RA (from step up)
inflammatory arthritis more than 3 joints, \>6 weeks, elevated CRP/ESR, + RF/ACPA, radiographic changes
62
drug of choice for pain control in RA
NSAIDs
63
best initial DMARD for RA
methotrexate
64
first line agent DMARDS for RA
methotrexate, leflunomide, hydroxychloroquine, sulfasalazine